ELREXFIO (elranatamab-bcmm) injection
ELREXFIO is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. FDA approved elranatamab-bcmm (brand name ELREXFIO) is not (yet) registered or available in India but on request Indian patient can buy ELREXFIO at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
ELREXFIO (elranatamab-bcmm) injection
Used for the Treatment of treat multiple myeloma (a type of cancer of the bone marrow) that has returned or that did not respond to at least 4 other treatments
ELREXFIO is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or
refractory multiple myeloma who have received at least four prior lines of therapy including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Elranatamab-bcmm is used to treat multiple myeloma (a type of cancer of the bone marrow) that has returned or that did not respond to at least 4 other treatments. Talquetamab-tgvs is in a class of medications called bispecific T-cell engager antibodies. It works by killing cancer cells.
Drug (Brand / Generic): ELREXFIO / elranatamab-bcmm
Current Indication: treat multiple myeloma
Approval Date: Aug 1, 2023
Injection:
• 76 mg/1.9 mL (40 mg/mL) in a single-dose vial.
• 44 mg/1.1 mL (40 mg/mL) in a single-dose vial.
Find Reference Updates
- For ELREXFIO (elranatamab-bcmm) injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- With FDA approval for Elrexfio, Pfizer brings multiple myeloma battle to Johnson & Johnson
- FDA Grants Accelerated Approval to Elrexfio for Relapsed/Refractory Multiple Myeloma
- Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ ELREXFIO (elranatamab-bcmm) injection ”. FDA approved elranatamab-bcmm (brand name ELREXFIO) is not (yet) registered or available in India but on request Indian patient can buy ELREXFIO at the lowest price. Confirmation of the order for ELREXFIO (elranatamab-bcmm) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved elranatamab-bcmm (brand name ELREXFIO) India.
For personal use, get access to FDA approved elranatamab-bcmm (brand name ELREXFIO) India. On request, We have imported and delivered Anti-cancer medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
ELREXFIO Sourcing & Delivery
Alleviare India specializes in sourcing and supplying ELREXFIO, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of ELREXFIO in India.
How much does ELREXFIO cost in the India?
Kindly reach out to us for ELREXFIO (elranatamab-bcmm) injection price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import ELREXFIO to India?
To import elranatamab-bcmm (brand name Elrexfio), patients or government hospitals can place an order on behalf of the patients.
The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is ELREXFIO available in India?
ELREXFIO elranatamab is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of ELREXFIO (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for ELREXFIO availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is elranatamab-bcmm (brand name Elrexfio) available in India?
Yes, FDA approved elranatamab-bcmm (brand name ELREXFIO) is not (yet) registered or available in India but on request Indian patient can buy ELREXFIO at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand ELREXFIO (elranatamab-bcmm) injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to ELREXFIO (elranatamab-bcmm) injection , they can inquire and find further information by sending their inquiries to ALS.
